ClinicalTrialsFinder
RecruitingNCT06106269

Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids

Hemorrhoidal Embolization Trial-1 (HEMBO-1)

Sponsor

Mayo Clinic

Enrollment

20 participants

Start Date

Jun 7, 2024

Study Type

OBSERVATIONAL

Conditions

Internal Hemorrhoid

Summary

This study will assess how effective and safe rectal artery embolization works to treat symptomatic bleeding predominant internal hemorrhoids.

Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Rectal Artery Embolization for people with internal hemorrhoid. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERectal Artery Embolization

Subjects will undergo planned rectal artery embolization (RAE) in Vascular and Interventional Radiology per standard clinical protocol.

Locations(1)

Mayo Clinic Minnesota

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06106269

Related Trials

Prospective HemorrhoIdaL EmboliSation (PILES) Registry

NCT076357841 location

Cap-assisted Endoscopic Sclerotherapy for Internal Hemorrhoids and Rectal Prolapse

NCT039170561 location

CAES for Internal Hemorrhoids and Rectal Prolapse

NCT041691521 location